{"company":{"id":1861135,"name":"Cellares","domain":"cellares.com","url":"https://alion.io/company/cellares"},"section":"news","answer":"Cellares: 12 headlines on record, 5 headlines in the last 90 days. Its story counts 7 milestones.","figures":[{"label":"Headlines","value":"12"},{"label":"In 90 days","value":"5"},{"label":"Milestones","value":"7"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":12},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":7}],"news":[{"date":"2026-09-24","kind":"News","title":"Korea's Seoul National University Hospital joins hands with Cellares for automated manufacturing of Gene-Modified HSPC therapy","source":"biospectrumasia.com","url":"https://biospectrumasia.com/news/26/28428/koreas-seoul-national-university-hospital-joins-hands-with-cellares-for-automated-manufacturing-of-gene-modified-hspc-therapy.html"},{"date":"2026-09-23","kind":"News","title":"Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks","source":"fiercepharma.com","url":"https://fiercepharma.com/manufacturing/cellares-pens-2nd-automation-test-asia-based-cell-therapy-outfit-2-weeks"},{"date":"2026-09-23","kind":"News","title":"Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle Platform","source":"rutlandherald.com","url":"https://rutlandherald.com/news/business/cellares-and-seoul-national-university-hospital-launch-proof-of-concept-for-automated-manufacturing-of-gene/article_ee7516ed-d9c4-5be1-8977-0a5a2d36e20d.html"},{"date":"2026-09-16","kind":"News","title":"Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts","source":"fiercepharma.com","url":"https://fiercepharma.com/manufacturing/cellares-links-genomefrontier-evaluate-virus-free-car-t-therapy-production"},{"date":"2026-09-16","kind":"News","title":"Cellares and GenomeFrontier Therapeutics Partner to Evaluate Automated Manufacturing for GF-CART01 on the Cell Shuttle Platform","source":"rutlandherald.com","url":"https://rutlandherald.com/news/business/cellares-and-genomefrontier-therapeutics-partner-to-evaluate-automated-manufacturing-for-gf-cart01-on-the-cell/article_5dfb7d74-b6b6-5657-aedf-fd93c34f4824.html"},{"date":"2026-07-13","kind":"News","title":"Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle Platform","source":"morningstar.com","url":"https://morningstar.com/news/business-wire/20260713700071/cellares-and-sonoma-biotherapeutics-collaborate-to-automate-manufacturing-of-sbt-77-7101-engineered-treg-cell-therapy-on-the-cell-shuttle-platform"},{"date":"2026-04-29","kind":"News","title":"Cellares to manufacture Cabaletta CAR-T under 10-year deal","source":"njbiz.com","url":"https://njbiz.com/cellares-manufacture-cabaletta-car-t-10-year-deal/"},{"date":"2026-04-14","kind":"Press release","title":"Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation","url":"https://cellares.com/cellares-raises-257-million-series-d-led-by-blackrock-and-eclipse-to-industrialize-global-cell-therapy-manufacturing-with-breakthrough-automation/"},{"date":"2025-12-01","kind":"News","title":"Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO","source":"YahooFinance","url":"https://finance.yahoo.com/news/cellares-appoints-former-maxcyte-commercial-140000308.html"},{"date":"2025-05-30","kind":"News","title":"Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing in Japan","source":"YahooFinance","url":"https://uk.finance.yahoo.com/news/cellares-mitsui-fudosan-announce-first-220000178.html"},{"date":"2025-03-24","kind":"News","title":"Inside the futuristic biotech startup Cellares that's building a cure for cancer with $355 million in funding","source":"Fortune","url":"https://fortune.com/2025/03/24/cellares-cell-therapy-biotech-new-jersey-venture-funding-bristol-myers-squibb/"},{"date":"2024-11-11","kind":"Press release","title":"Cellares Appoints Ossama Eissa, Former Novartis, Lonza and Legend Biopharma Leader, as Chief Operating Officer","source":"businesswire.com","url":"https://businesswire.com/news/home/20241112242499/en/Cellares-Appoints-Ossama-Eissa-Former-Novartis-Lonza-and-Legend-Biopharma-Leader-as-Chief-Operating-Officer/"}],"story":[{"title":"Partnership Cellares and GenomeFrontier Therapeutics Partner to Evaluate Automated Manufacturing for GF-CART01 on the Cell Shuttle Platform · rutlandherald.com","url":"https://rutlandherald.com/news/business/cellares-and-genomefrontier-therapeutics-partner-to-evaluate-automated-manufacturing-for-gf-cart01-on-the-cell/article_5dfb7d74-b6b6-5657-aedf-fd93c34f4824.html"},{"title":"Layoffs"},{"title":"Raised a round Series D $257M · led by BlackRock","url":"https://cellares.com/cellares-raises-257-million-series-d-led-by-blackrock-and-eclipse-to-industrialize-global-cell-therapy-manufacturing-with-breakthrough-automation/"},{"title":"New executive Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of… · YahooFinance","url":"https://finance.yahoo.com/news/cellares-appoints-former-maxcyte-commercial-140000308.html"},{"title":"New executive Cellares Appoints Ossama Eissa, Former Novartis, Lonza and Legend Biopharma Leader, as Chief Operating Officer · businesswire.com","url":"https://businesswire.com/news/home/20241112242499/en/Cellares-Appoints-Ossama-Eissa-Former-Novartis-Lonza-and-Legend-Biopharma-Leader-as-Chief-Operating-Officer/"},{"title":"Raised a round Venture round $82M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1861651/000186165121000001/"},{"title":"Founded"}],"as_of":"2026-11-17","cite":"Cellares, News. Alion, Nov 17, 2026. https://alion.io/company/cellares/news","html_url":"https://alion.io/company/cellares/news","json_url":"https://alion.io/company/cellares/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T18:00:50Z"}}